Minnesota SF 1640: Prescription Drug Pricing Transparency Act

Status: Chief author added Draheim (as of 2019-03-25)

State: Minnesota · Session: 2019-2020 · Bill: SF 1640

Subjects: Drugs and Medicine, Health and Health Department, Human Rights and Human Rights Department, Popular Names

Sponsors: Draheim, Hayden, Little, Nelson, Rosen

View Minnesota SF 1640 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.